Provided by Tiger Fintech (Singapore) Pte. Ltd.

LivaNova PLC

40.30
-0.5450-1.33%
Volume:383.51K
Turnover:15.46M
Market Cap:2.19B
PE:34.74
High:40.95
Open:40.48
Low:39.86
Close:40.84
Loading ...

Company Profile

Company Name:
LivaNova PLC
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
2900
Office Location:
20 Eastbourne Terrace,London,Greater London,United Kingdom
Zip Code:
W2 6LG
Fax:
- -
Introduction:
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Directors

Name
Position
Damien McDonald
CEO and Executive Director
Daniel J. Moore
Chair of the Boar
Alfred J. Novak
Director
Andrea L. Saia
Director
Arthur L. Rosenthal
Director
Francesco Bianchi
Director
Sharon O'Kane
Director
Stacy Enxing Seng
Director
Todd Schermerhorn
Director
William Kozy
Director

Shareholders

Name
Position
Alex Shvartsburg
Interim Chief Financial Officer
Keyna Skeffington
Senior Vice President, General Counsel and Corporate Secretary
Damien McDonald
CEO and Executive Director
Marco Dolci
Head of Global Operations and R,D
Trui Hebbelinck
Chief Human Resources Officer